Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02274857 · ClinicalTrials.gov registry record · NA
Randomized Evaluation of Atrial Fibrillation Treatment With Focal Impulse and Rotor Modulation Guided Procedures
A NA study of Persistent Atrial Fibrillation, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 350
- Enrollment target
- 18
- Study locations
NCT02274857 is a NA study of Persistent Atrial Fibrillation that has completed, run by Abbott Medical Devices. The registered enrollment target is 350 participants, below the 1,237-participant average among 15 other Persistent Atrial Fibrillation trials with a reported enrollment target (72% lower). The trial reports 18 study locations across 11 states.
The verdict
NCT02274857, a NA study of Persistent Atrial Fibrillation, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 350 participants
- Enrollment target
- 18
- Study locations
Study Summary
The study is a prospective, multicenter, randomized study to assess the safety and effectiveness of FIRM procedures followed by conventional ablation including PVI versus a standard PVI procedure for the treatment of persistent atrial fibrillation (AF).
Conditions Studied
Interventions
- PROCEDURE Standard PVI Ablation
- PROCEDURE FIRM-Guided Procedure and PVI
Study Locations (18)
Other
- Unfallkrankenhaus Berlin - Berlin
- Klinikum Coburg GmbH - Coburg
- Zentrum für klinische Prüfungen in der Facharztzentrum Dresden-Neustadt GbR - Dresden
- Städtisches Klinikum Karlsruhe gGmbH - Karlsruhe
- Leipzig Heart Institute GmbH - Leipzig
- Kardiologische Gemeinschaftspraxis am Park Sanssouci - Potsdam
- Erasmus Medical Center - Rotterdam
Indiana
- Indiana University - Krannert Institute of Cardiology - Indianapolis
- St. Vincent Hospital - Indianapolis
Arizona
- Arizona Heart Rhythm Center - Phoenix
California
- Hoag Memorial Hospital Presbyterian - Newport Beach
Illinois
- Loyola University Medical Center - Maywood
Maryland
- The Johns Hopkins Hospital - Baltimore
New Jersey
- Hackensack UMC - Hackensack
New York
- Weill Medical College at Cornell University - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2014-10 |
| Est. Completion | 2018-11-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02274857
The ClinicalTrials.gov registry entry for NCT02274857 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 350 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,237-participant average among 15 other Persistent Atrial Fibrillation trials with a reported enrollment target (72% lower). The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Persistent Atrial Fibrillation appearing as the primary indexed condition, and to 2 interventions - of which Standard PVI Ablation is the first listed.
NCT02274857 reports 18 study locations spanning 11 distinct geographic areas - top geographies include Other, Indiana, Arizona.
Frequently Asked Questions
What is clinical trial NCT02274857 about?
NCT02274857 is a clinical study titled "Randomized Evaluation of Atrial Fibrillation Treatment With Focal Impulse and Rotor Modulation Guided Procedures". The study is a prospective, multicenter, randomized study to assess the safety and effectiveness of FIRM procedures followed by conventional ablation including PVI versus a standard PVI procedure for the treatment of persistent atrial fibrillation (AF).
What is the current status of trial NCT02274857?
This trial is currently completed. It is a NA study. The enrollment target is 350 participants. The study started on 2014-10. Estimated completion is 2018-11-10.
What conditions does trial NCT02274857 study?
This clinical trial studies the following conditions: Persistent Atrial Fibrillation.
What interventions are being tested in trial NCT02274857?
The interventions under investigation include: Standard PVI Ablation (PROCEDURE), FIRM-Guided Procedure and PVI (PROCEDURE).
Who is sponsoring clinical trial NCT02274857?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02274857 being conducted?
This trial has 18 study locations across Arizona, California, Illinois, Indiana, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Persistent Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Endocardial Mapping With the CoreMap EP Mapping System
RECRUITING · NA
-
ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients
RECRUITING · NA
-
ARIADNE Clinical Trial
RECRUITING · NA
-
Medtronic Terminate AF Study
RECRUITING · NA
-
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System
RECRUITING · NA
-
Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.